MCh Pediatric Orthopedics: Admission, Medical School, Fees, Eligibility Criteria

Published Date: 06 Mar 2023

The Master Chirurgiae in Pediatric Orthopedics, also known as MCh Pediatric Orthopedics or MCh in Pediatric Orthopedics, is the highest degree...

Read Full News

Latest News

Study Finds Huge Regional Variability in 'Low-Value' Orthopedic Services for Vets

— Patients in one place may get Medicare-paid procedures 10 times as often as elsewhere

Study 'Challenges' Standard of Prolonged Antibiotics for Orthopedic Infections

— Local antibiotic implants during surgery may have helped shorten postoperative systemic regimens

One Active Joint Left in Inflammatory Arthritis: What to Do?

Despite being a clinical scenario familiar to any rheumatologist, little evidence exists to guide treatment decisions for inflammatory arthritis limited to a single major joint.

AbbVie's Blood Cancer Therapy Lowers Disease Progression, Death Risk in Trial

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

Less Frequent Monitoring May Be Safe in Patients on MTX

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

Gout Tied to Elevated Fracture Risk; Drug Adherence Helps

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

Todays Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Todays Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Latest News

— Patients in one place may get Medicare-paid procedures 10 times as often as elsewhere

— Local antibiotic implants during surgery may have helped shorten postoperative systemic regimens

Despite being a clinical scenario familiar to any rheumatologist, little evidence exists to guide treatment decisions for inflammatory arthritis limited to a single major joint.

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

News All Time

Rare Case of Multiple Myeloma in Teenage Girl

Successful use of affordable induction therapy with autologous stem cell transplantation

Multi-Joint Arthritis Bodes Poorly for Healthy Aging

Osteoarthritis extent tied to increased frailty, even after adjusting for physical activity

Can Creatine Help Non-Athletes? A Physical Therapist Weighs In

Creatine may have less risk than other supplements, but who might benefit is unclear

Synovitis Confirmed as Prognostic in Hand Osteoarthritis, Regardless of Subtype

— Doesn't matter whether it's in the first carpometacarpal or interphalangeal joints

Denosumab May Protect Joints in Adults With Osteoporosis

Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.

Straight Talk on Scoliosis Screening in Primary Care

Pediatricians can and should screen for scoliosis, especially in teens who are still growing.

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Did Your Patient’s Cane Kill Them?

Mobility assistance devices may be harmful if not prescribed properly

Trial Casts Doubt on Antibiotics for Refractory Low Back Pain

Now it's up to clinicians to sort out conflicting evidence

GLP-1 Drugs Tied to Lower Need for Knee Replacement

But what drives the apparent effect remains unknown. Is it the weight loss or other factors?

Top Pro Athletes Credit a Tiny New Scope for Their Faster Recoveries

There's little published research, but a small, flexible arthroscope is accumulating proponents

Cancer Diagnosis Delays During Screening Study; Benefits of Resistance Training

Also in TTHealthWatch: GLP-1 agonists and knee replacement

Woman's Ice-Skating Fall Produces Striking X-Ray, Rare Forearm Break

While Monteggia fracture is uncommon in adults, early intervention is crucial

The World Cup Is a Celebration of Sport. It's Also a Warning About Climate Change.

The tournament is a preview for how outdoor activities are being reshaped globally

Why Some 'Old' Soccer Players Like Messi, Ronaldo Can Still Kick It in the World Cup

Advancements in training and recovery means elite athletes are playing longer than ever before

Recommended News For You

Integrative palliative care is critical to improving mental health among pancreatic cancer patients

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

Do I qualify for a cancer clinical trial?

Mapping lifelong chronic health risks for childhood cancer survivors

ALK-positive lung cancer trial results show unprecedented progression-free survival.

Recommended Articles For You

Understanding Fibrosarcoma: What You Need to Know  

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression 

Pharmacokinetics of Antibody–Drug Conjugates 

Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

2.

Study shows virtual reality headsets may help ease cancer pain

3.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

4.

Some low-grade prostate cancers carry higher risks than biopsy suggests

5.

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

1.

The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery

2.

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring

3.

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration

4.

Molecular Matching for Complex Blood Disorders

5.

Quality of Life Through Identity Reconstruction and Social Reintegration After Cancer Treatment

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot